HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validation of a symptom diary for patients with gastro-oesophageal reflux disease.

AbstractBACKGROUND:
Symptom diaries are potentially attractive but, because of concerns about patient compliance, they have had limited use in clinical trials. We assessed the validity and responsiveness of a symptom diary for patients with gastro-oesophageal reflux disease.
METHODS:
We included 215 patients with gastro-oesophageal reflux disease after starting treatment for 4 weeks with 40 mg esomeprazole once daily. Patients recorded whether they experienced night-time heartburn (yes/no), the severity of daytime heartburn on a scale from 1 (no heartburn) to 4 (severe heartburn) and their antacid use. Patients also completed a number of disease-specific and preference-based Health-related Quality of Life questionnaires at baseline and follow-up.
RESULTS:
Consistent with a priori predictions, daytime heartburn showed moderate to strong correlations with the Quality of Life in Reflux and Dyspepsia questionnaire (0.36-0.67) and four scales of symptom severity (0.36-0.70) for baseline, follow-up and change scores, but low correlations with the Standard Gamble. Responsiveness of the daytime heartburn item was excellent with a mean change from baseline to follow-up of -1.3 (95% CI -1.4 to -1.1) and a standardized response mean of 1.33 while responsiveness of the daily antacid use item was moderate (mean change scores -1.8 tablets taken, 95% CI -2.3 to -1.3 and standardized response mean of 0.64).
CONCLUSIONS:
The excellent psychometric properties of this simple gastro-oesophageal reflux disease diary make it an attractive measure for future trials.
AuthorsM A Puhan, G H Guyatt, D Armstrong, I Wiklund, C A Fallone, D Heels-Ansdell, A Degl'Innocenti, S J O Veldhuyzen van Zanten, L Tanser, A N Barkun, N Chiba, P Austin, S El-Dika, H J Schünemann
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 23 Issue 4 Pg. 531-41 (Feb 15 2006) ISSN: 0269-2813 [Print] England
PMID16441474 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Antacids
  • Anti-Ulcer Agents
  • Esomeprazole
Topics
  • Antacids (therapeutic use)
  • Anti-Ulcer Agents (therapeutic use)
  • Cross-Sectional Studies
  • Esomeprazole (therapeutic use)
  • Female
  • Gastroesophageal Reflux (complications, drug therapy)
  • Heartburn (drug therapy, etiology)
  • Humans
  • Longitudinal Studies
  • Male
  • Medical Records
  • Middle Aged
  • Quality of Life
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: